PSG will begin by analyzing and evaluating your current prescription drug strategy, performance, internal capabilities, and existing contract. This results in fact-driven recommendations to ensure that you are getting maximum financial value from the program while enhancing the quality of care offered to your members/employees.
Plan design features are crucial for encouraging members/employees to use more cost-effective medications and delivery channels. PSG uses its comprehensive data warehouse and modeling capabilities to evaluate alternative and evidence-based plan designs that will accomplish your benefit plan goals.
We start by benchmarking current utilization patterns and trends in key therapeutic classes that drive the majority of cost and have the greatest opportunity for savings. Next, we consider alternative plan designs and channels that influence members/employees or to improve behaviors around using lower-cost alternatives and adhering more effectively to treatment guidelines.
PSG’s Plan Strategy and Design Solutions, combined with evaluation of your clinical programs, ensures proper alignment for member/employee financial incentives. The outcome of this benchmarking and plan design evaluation gives you the ability to assess the financial impact accurately and minimize disruption for members/employees.